Blog articles


Pharmacogenomics: three challenges to the NHS

Last week we explored the promise of pharmacogenomics in the health service, but there are good reasons why it will take time to implement
cancer therapy

Pharmacogenomics: a new normal for the NHS?

The analysis of the genomic determinants of drug response is a hot topic in healthcare and was the focus for a workshop last month
Rare-disease-family

UK rare disease strategy: the plan for implementation

Four years on from the government’s rare disease strategy, its implementation plan has been published. Here’s our summary of the key areas of focus

Ethical editing: therapeutics and ‘enhancement’

A newly published report takes a different approach towards the controversial editing of human genomes

Genomics in government policy

How do we bring exciting research, exceptional medicine and public opinion to routine clinical practice?

Personalised medicine in the NHS: what will it mean?

Moving away from trial and error treatments to patient care tailored to your unique genetic makeup  

News articles


GEP welcomes release of Topol Review

HEE’s newly published report outlines key recommendations for the NHS’s digital future and has genomics as a key focus

UK Strategy for Rare Diseases progress report released

Report tracks progress made against 51 commitments in UK Strategy…
Genomics lab

Generation Genome: delivering genomics to the NHS

In her annual report, Dame Sally Davies reveals her enthusiasm for genomics and how it can transform diagnosis and treatment for NHS patients 

Events


Royal College of Physicians Annual Conference 2020

The sixth Royal College of Physicians annual conference, Medicine 2020, takes place in Birmingham on 23–24 April 2020.
Manchester Central Complex

NHS Health and Care Innovation Expo 2019

The NHS Health and Care Innovation Expo 2019 is focused on bringing the NHS Long Term Plan to life.

NHS Confederation 2019

This year, NHS Confederation will focus on the future of the NHS and healthcare and this theme will be supported by many new conference strands.